Licensing
MorphoSys Thins Pipeline For Potential $1 Billion Deal While Progressing Oncology Ambitions
2022-06-16
Denali Taps PharmEnable to Discover AI-Based Small Molecule Candidates for Neurological Diseases
2022-05-30